4 小时
Zacks Investment Research on MSNFDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for ReviewDr. Reddy’s Laboratories RDY and partner, Alvotech ALVO, announced the FDA’s acceptance of a regulatory filing, seeking the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果